Table 4.

Therapeutic Response of InLuDOTA PRRT in 322 patients with progressive disease prior to InLuDOTA PRRT

Response	Symptomatic response evaluation (No. of patients)	Biochemical response evaluation in 321 patients (No. of patients)	RECIST 1.1 (No. of patients)	PERCIST (No. of patients)
Complete Response	138 (42.8%)	43 (13.4%)	13 (4%)	23 (7.1%)
Partial Response	72 (22.4%)	127 (39.6%)	86 (26.7%)	83 (25.8%)
Stable Disease	91 (28.3%)	114 (35.5%)	188 (58.4%)	177 (55%)
Progressive Disease	21 (6.5%)	37 (11.5%)	35 (10.9%)	39 (12.1%)